Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 11:23 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 649–672 of 3,553 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Fluids Clear all

Conditions: Ocular Inflammation, Crystalline Lens; Chalcosis, Intraocular Lens Complication
Interventions: Cymbathera One System; Device
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 7
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more

Conditions: Breast Cancer
Interventions: Research Cardiac MRI, Biomarkers; Procedure
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years and older · Female only
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Lipid Disorder, Dyslipidemias, Aortic Stiffness, Insulin Resistance Syndrome, Metabolic Syndrome, Pediatric Obesity
Interventions: CS-; Dietary Supplement
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 11 Years to 21 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Fracture
Interventions: Arthrocentesis/PRP, Arthrocentesis/Saline; Biological · Drug
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 18 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Leukemia
Interventions: filgrastim, asparaginase, cyclophosphamide, cytarabine, daunorubicin hydrochloride, dexamethasone, etoposide, idarubicin, leucovorin calcium, mercaptopurine, methotrexate, prednisone, vincristine sulfate, radiation therapy; Biological · Drug · Radiation
Lead sponsor: Children's Oncology Group; Network
Eligibility: Up to 17 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2007
U.S. locations: 51
States / cities: Tucson, Arizona • Palo Alto, California • Sacramento, California + 44 more

Conditions: Hyponatremia
Interventions: PEG-SD, PEG-ELS; Drug
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years and older
Enrollment: 460 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Gastric Cancer, Gastric Adenocarcinoma, Gastric Cancer Stage, Gastric Neoplasm, Gastric Lesion, Gastric Cancer in Situ, Gastric Cancer Stage IV, Gastric Cancer Stage IIIB, Gastric Cancer Stage III, Gastric Cancer Stage IB, Gastric Cancer Stage IA, Gastric Cancer, Stage 0, Gastric Cancer Stage IIIA, Gastric Cancer Stage II, Gastric Cancer TNM Staging, Gastric Cancer Metastatic to Lung, Gastric Cancer Metastatic to Liver, Gastric Cancer Stage I, Gastric Cancer TNM Staging Primary Tumor (T) T2B
Interventions: DESTINEX; Diagnostic Test
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 809 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Duarte, California

Conditions: Obstructive Sleep Apnea
Interventions: OSA LLLT treatment device, Sham Comparator; Device
Lead sponsor: Photonica USA, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 35 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 2
States / cities: Miami, Florida • Miramar, Florida

Conditions: Burns
Interventions: ReCell; Device
Lead sponsor: Avita Medical; Industry
Eligibility: 5 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 6
States / cities: Phoenix, Arizona • Washington D.C., District of Columbia • Tampa, Florida + 3 more

Conditions: Pancreatic Duct Strictures, Biliary Duct Strictures
Interventions: Sample Collection; Other
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 19 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Hydrocephalus
Interventions: Ventriculoperitoneal shunt insertion surgery; Procedure
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 1 Day to 17 Years
Enrollment: 448 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 11
States / cities: Birmingham, Alabama • Los Angeles, California • Denver, Colorado + 8 more

Conditions: Tobacco Dependence
Interventions: Nicotine-Containing Electronic Cigarette, Non-Nicotine Electronic Cigarette; Other
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 21 Years to 70 Years
Enrollment: 105 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Constipation, Post-Op Complication
Interventions: Polyethylene Glycol Powder; Drug
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years to 89 Years · Female only
Enrollment: 71 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Bay Shore, New York

Conditions: Relapsed Multiple Myeloma
Interventions: ATRA, Celecoxib, Itraconazole; Drug
Lead sponsor: University of Iowa; Other
Eligibility: 18 Years to 75 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Growth Disorders, Dietary Exposure, Child Development, Bone Development Abnormal, Body Weight, Child Malnutrition
Interventions: TruHeight Growth Protein Shake; Dietary Supplement
Lead sponsor: TruHeight Vitamins; Industry
Eligibility: 4 Years to 17 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Chronic Inflammatory Demyelinating Polyneuropathy
Interventions: Immune Globulin Subcutaneous (Human); Drug
Lead sponsor: University of South Florida; Other
Eligibility: 18 Years to 80 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2021
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Breast Reduction, Breast Reconstruction
Interventions: Ketorolac Tromethamine, Saline; Drug · Other
Lead sponsor: Carilion Clinic; Other
Eligibility: 18 Years to 64 Years · Female only
Enrollment: 183 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Roanoke, Virginia

Conditions: Overactive Bladder, Stress, Psychological, Anxiety
Interventions: Psychological stress induction, Accelerated oral hydration; Behavioral · Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 97 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Abnormal Uterine Bleeding (AUB), Endometrial Cancer, Atypical Endometrial Hyperplasia, Endometrial Hyperplasia With Atypia, Endometrial Intraepithelial Neoplasia
Interventions: Not listed
Lead sponsor: Exact Sciences Corporation; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 4,200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 5
States / cities: Sarasota, Florida • Scarborough, Maine • Murfreesboro, Tennessee + 1 more

Conditions: Heart Failure, Congestive Heart Failure
Interventions: WhiteSwell System; Device
Lead sponsor: WhiteSwell, Limited; Industry
Eligibility: 18 Years and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 2
States / cities: Naperville, Illinois • Columbus, Ohio

Conditions: Eosinophilic Esophagitis
Interventions: Barium Esophagram, EsophaCap, Physical Examination and Questionnaires; Diagnostic Test · Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Choroidal Melanoma
Interventions: 1000CsK Silicon Oil Tamponade; Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2021
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: HIV Infections
Interventions: Not listed
Lead sponsor: Chembio Diagnostic Systems, Inc.; Industry
Eligibility: 12 Years and older
Enrollment: 101 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Dehydration, Head & Neck Cancer, Esophageal Cancer
Interventions: Gatorade G2, Standard of care nutritional support; Dietary Supplement
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Cleveland, Ohio

Search by objective public record fields.

A Study of Ear Nerve Stimulation to Treat Eye Inflammation

Biomarkers and Cardiac MRI as Early Indicators of Cardiac Exposure Following Breast Radiotherapy

Causal Mechanisms in Adolescent Arterial Stiffness

Platelet Rich Plasma Injection in Pilon Fractures

Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia

Incidence of Hyponatremia in PEG-SD Compared to PEG-ELS

Stomach Cancer Exosome-based Detection

Alesis OSA-1 Obstructive Sleep Apnea Treatment

CONTINUED ACCESS PROTOCOL: Demonstration of the Safety and Effectiveness of ReCell® Combined With Meshed Skin Graft for Reduction of Donor Area in the Treatment of Acute Burn Injuries

Bile and Bile Duct/Pancreatic Duct Brushings Database for Patients With Pancreato-biliary Stricture

The CSF Shunt Entry Site Trial

Does Switching to Nicotine Containing Electronic Cigarettes Reduce Health Risk Markers

Does a Preoperative Bowel Regimen Change Time to First Bowel Movement After Robotic Sacral Colpopexy

ATRA, Celecoxib, and Itraconazole as Maintenance

Evaluating the Effects of an Oral Protein Supplement on Children's Growth Patterns

Subcutaneous Immunoglobulin for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Toradol (Ketorolac) in Breast Surgery to Reduce Pain & Opioid Use

Stress and Anxiety Effects on Overactive Bladder

Endometrial Cancer Vaginal Fluid Specimen Collection Study

Safety and Feasibility of the WhiteSwell System"

Natural History of Eosinophilic Esophagitis

Safety and Efficacy of Silicone Oil Tamponade for Surgical Attenuation of Radiation Damage in Choroidal Melanoma

Evaluation of the DPP HIV 1/2 Test and the HIV 1/2 Stat Pak Test Using Oral Fluid

DRIHNC - Dehydration Reduction in Head & Neck Cancer